Sign in
4

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0001662579-23-000037

Chief Business Officer acquired 20,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Boyle Scott N · Chief Business Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2023-02-13 Grant or award : show line 1 in the form +20,000 25,176 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-02-13 Grant or award : show line 2 in the form Stock Option (Right to Buy) +90,000 90,000 D
Loading xslF345X03/wf-form4_167649750908844.xml…